1. Home
  2. ELTX vs ACR Comparison

ELTX vs ACR Comparison

Compare ELTX & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • ACR
  • Stock Information
  • Founded
  • ELTX 2011
  • ACR 2005
  • Country
  • ELTX United States
  • ACR United States
  • Employees
  • ELTX N/A
  • ACR N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • ACR Real Estate Investment Trusts
  • Sector
  • ELTX Health Care
  • ACR Real Estate
  • Exchange
  • ELTX Nasdaq
  • ACR Nasdaq
  • Market Cap
  • ELTX 121.7M
  • ACR 139.0M
  • IPO Year
  • ELTX N/A
  • ACR N/A
  • Fundamental
  • Price
  • ELTX $8.09
  • ACR $17.78
  • Analyst Decision
  • ELTX Strong Buy
  • ACR Buy
  • Analyst Count
  • ELTX 2
  • ACR 2
  • Target Price
  • ELTX $9.50
  • ACR $17.50
  • AVG Volume (30 Days)
  • ELTX 46.9K
  • ACR 78.4K
  • Earning Date
  • ELTX 08-12-2025
  • ACR 07-30-2025
  • Dividend Yield
  • ELTX N/A
  • ACR N/A
  • EPS Growth
  • ELTX N/A
  • ACR N/A
  • EPS
  • ELTX N/A
  • ACR 0.34
  • Revenue
  • ELTX N/A
  • ACR $83,545,000.00
  • Revenue This Year
  • ELTX N/A
  • ACR $3.57
  • Revenue Next Year
  • ELTX N/A
  • ACR N/A
  • P/E Ratio
  • ELTX N/A
  • ACR $51.85
  • Revenue Growth
  • ELTX N/A
  • ACR 6.92
  • 52 Week Low
  • ELTX $3.70
  • ACR $13.47
  • 52 Week High
  • ELTX $9.99
  • ACR $23.81
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 62.14
  • ACR 47.60
  • Support Level
  • ELTX $7.76
  • ACR $17.59
  • Resistance Level
  • ELTX $8.94
  • ACR $18.10
  • Average True Range (ATR)
  • ELTX 0.37
  • ACR 0.47
  • MACD
  • ELTX -0.03
  • ACR 0.05
  • Stochastic Oscillator
  • ELTX 51.09
  • ACR 51.44

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.

Share on Social Networks: